Search

Your search keyword '"Fiorentino, Michelangelo"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Fiorentino, Michelangelo" Remove constraint Author: "Fiorentino, Michelangelo" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
83 results on '"Fiorentino, Michelangelo"'

Search Results

1. Supplementary Figure from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

2. Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

3. Abstract 737: Variation in prognostic value of Gleason score for lethal prostate cancer using time-varying area under the curve

4. Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

6. Supplementary Figure 1 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

7. Supplementary Figure 4 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

9. Supplementary Figure 2 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

11. Supplementary Figure 3 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

13. Supplementary Tables 1-5, Supplementary Figures 1-3 from Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions

14. Supplementary Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

15. Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

16. Supplementary Table 1 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

18. Supplementary Table 4 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer

19. Supplementary Figure 1 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis

21. Supplementary Table 3 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis

22. Supplementary Table 3 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer

23. Data from Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer

24. Supplementary Table 1 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer

25. Data from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis

27. Supplementary Figure 1 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer

28. Supplementary Table 2 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer

29. Supplementary Tables 1, 2, 4 and 5 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis

30. Data from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer

31. Supplementary Table S1 from Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer

36. Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions

37. AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

38. Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

39. Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer

40. A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer

42. Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer

43. Perineural Invasion and Risk of Lethal Prostate Cancer

44. Prognostic Utility of a New mRNA Expression Signature of Gleason Score

46. MET DNA Alterations in NSCLC—Letter

47. Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer

48. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer

49. SPINK1 Protein Expression and Prostate Cancer Progression

50. Prostate-Specific Membrane Antigen Protein Expression in Tumor Tissue and Risk of Lethal Prostate Cancer

Catalog

Books, media, physical & digital resources